These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 22296623

  • 1. Ritonavir interacts with bortezomib to enhance protein ubiquitination and histone acetylation synergistically in renal cancer cells.
    Sato A, Asano T, Ito K, Asano T.
    Urology; 2012 Apr; 79(4):966.e13-21. PubMed ID: 22296623
    [Abstract] [Full Text] [Related]

  • 2. Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically.
    Sato A, Asano T, Ito K, Sumitomo M, Asano T.
    BJU Int; 2012 Apr; 109(8):1258-68. PubMed ID: 21895936
    [Abstract] [Full Text] [Related]

  • 3. Vorinostat and bortezomib synergistically cause ubiquitinated protein accumulation in prostate cancer cells.
    Sato A, Asano T, Ito K, Asano T.
    J Urol; 2012 Dec; 188(6):2410-8. PubMed ID: 23088964
    [Abstract] [Full Text] [Related]

  • 4. Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells.
    Sato A, Asano T, Isono M, Ito K, Asano T.
    BMC Urol; 2014 Aug 30; 14():71. PubMed ID: 25176354
    [Abstract] [Full Text] [Related]

  • 5. Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.
    Nawrocki ST, Carew JS, Pino MS, Highshaw RA, Andtbacka RH, Dunner K, Pal A, Bornmann WG, Chiao PJ, Huang P, Xiong H, Abbruzzese JL, McConkey DJ.
    Cancer Res; 2006 Apr 01; 66(7):3773-81. PubMed ID: 16585204
    [Abstract] [Full Text] [Related]

  • 6. Combination of suberoylanilide hydroxamic acid and ritonavir is effective against renal cancer cells.
    Sato A, Asano T, Horiguchi A, Ito K, Sumitomo M, Asano T.
    Urology; 2010 Sep 01; 76(3):764.e7-13. PubMed ID: 20630573
    [Abstract] [Full Text] [Related]

  • 7. Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells.
    Dai Y, Chen S, Kramer LB, Funk VL, Dent P, Grant S.
    Clin Cancer Res; 2008 Jan 15; 14(2):549-58. PubMed ID: 18223231
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells.
    Karthik S, Sankar R, Varunkumar K, Ravikumar V.
    Biomed Pharmacother; 2014 Apr 15; 68(3):327-34. PubMed ID: 24485799
    [Abstract] [Full Text] [Related]

  • 10. The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis.
    Zhang QL, Wang L, Zhang YW, Jiang XX, Yang F, Wu WL, Janin A, Chen Z, Shen ZX, Chen SJ, Zhao WL.
    Leukemia; 2009 Aug 15; 23(8):1507-14. PubMed ID: 19282831
    [Abstract] [Full Text] [Related]

  • 11. Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis.
    Kraus M, Malenke E, Gogel J, Müller H, Rückrich T, Overkleeft H, Ovaa H, Koscielniak E, Hartmann JT, Driessen C.
    Mol Cancer Ther; 2008 Jul 15; 7(7):1940-8. PubMed ID: 18645004
    [Abstract] [Full Text] [Related]

  • 12. Effect of noncompetitive proteasome inhibition on bortezomib resistance.
    Li X, Wood TE, Sprangers R, Jansen G, Franke NE, Mao X, Wang X, Zhang Y, Verbrugge SE, Adomat H, Li ZH, Trudel S, Chen C, Religa TL, Jamal N, Messner H, Cloos J, Rose DR, Navon A, Guns E, Batey RA, Kay LE, Schimmer AD.
    J Natl Cancer Inst; 2010 Jul 21; 102(14):1069-82. PubMed ID: 20505154
    [Abstract] [Full Text] [Related]

  • 13. Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib.
    Kardosh A, Golden EB, Pyrko P, Uddin J, Hofman FM, Chen TC, Louie SG, Petasis NA, Schönthal AH.
    Cancer Res; 2008 Feb 01; 68(3):843-51. PubMed ID: 18245486
    [Abstract] [Full Text] [Related]

  • 14. Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer Cells.
    Isono M, Sato A, Asano T, Okubo K, Asano T.
    Anticancer Res; 2018 Jun 01; 38(6):3493-3500. PubMed ID: 29848702
    [Abstract] [Full Text] [Related]

  • 15. The Dual Histone Deacetylase-Proteasome Inhibitor RTS-V5 Acts Synergistically With Ritonavir to Induce Endoplasmic Reticulum Stress in Bladder Cancer Cells.
    Okubo K, REßING N, Schulz WA, Hansen FK, Asano T, Sato A.
    Anticancer Res; 2021 Dec 01; 41(12):5987-5996. PubMed ID: 34848452
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo.
    Huang H, Liu N, Yang C, Liao S, Guo H, Zhao K, Li X, Liu S, Guan L, Liu C, Xu L, Zhang C, Song W, Li B, Tang P, Dou QP, Liu J.
    PLoS One; 2012 Dec 01; 7(12):e52576. PubMed ID: 23285100
    [Abstract] [Full Text] [Related]

  • 19. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma.
    Heider U, Rademacher J, Lamottke B, Mieth M, Moebs M, von Metzler I, Assaf C, Sezer O.
    Eur J Haematol; 2009 Jun 01; 82(6):440-9. PubMed ID: 19220424
    [Abstract] [Full Text] [Related]

  • 20. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis.
    Gaedicke S, Firat-Geier E, Constantiniu O, Lucchiari-Hartz M, Freudenberg M, Galanos C, Niedermann G.
    Cancer Res; 2002 Dec 01; 62(23):6901-8. PubMed ID: 12460905
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.